Headline News about Incyte Corp![]() ![]()
Ominous Death Cross Forms On Incyte's Chart
April 13, 2023
Via Benzinga
![]() ![]() ![]() Via Benzinga
![]()
What 13 Analyst Ratings Have To Say About Incyte
March 28, 2023
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
Analyst Expectations for Incyte's Future
March 07, 2023
Via Benzinga
![]()
Incyte's Return On Capital Employed Overview
February 08, 2023
Via Benzinga
![]()
Analyst Ratings for Incyte
February 08, 2023
Via Benzinga
![]()
Earnings Outlook For Incyte
February 06, 2023
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
January 31, 2023
Via Benzinga
![]() ![]() ![]()
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
Via Talk Markets
![]() ![]() Via Talk Markets
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|